0000874015-12-000028.txt : 20120622 0000874015-12-000028.hdr.sgml : 20120622 20120622194652 ACCESSION NUMBER: 0000874015-12-000028 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20120622 FILED AS OF DATE: 20120622 DATE AS OF CHANGE: 20120622 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: ISIS PHARMACEUTICALS INC CENTRAL INDEX KEY: 0000874015 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 330336973 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 2855 GAZELLE COURT CITY: CARLSBAD STATE: CA ZIP: 92010 BUSINESS PHONE: 7609319200 MAIL ADDRESS: STREET 1: 2855 GAZELLE COURT CITY: CARLSBAD STATE: CA ZIP: 92010 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: REED JOHN C CENTRAL INDEX KEY: 0001181561 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 000-19125 FILM NUMBER: 12923394 MAIL ADDRESS: STREET 1: 2855 GAZELLE COURT CITY: CARLSBAD STATE: CA ZIP: 92010 4 1 edgar.xml PRIMARY DOCUMENT X0305 4 2012-06-22 0000874015 ISIS PHARMACEUTICALS INC ISIS 0001181561 REED JOHN C C/O ISIS PHARMACEUTICALS, INC. 2855 GAZELLE COURT CARLSBAD CA 92010 1 0 0 0 Common Stock 2012-06-22 2012-06-22 4 M 0 10000 8.15 A 10000 D Common Stock 2012-06-22 2012-06-22 4 S 0 10000 11.06 D 0 D Director Stock Option (right to buy) 8.15 2012-06-22 2012-06-22 4 M 0 10000 0 D 2006-07-01 2012-06-30 Common Stock 10000 0 D Acquired as a result of exercising a stock option that was scheduled to expire on 6/30/12. The purchase and sale reported on this Form 4 was effective pursuant to a Rule 10b5-1 Trading Plan adopted by the reporting person on 10/3/11. /s/B. Lynne Parshall, Attorney-in-Fact 2012-06-22